Feasibility of boron neutron capture therapy (BNCT) for malignant pleural mesothelioma from a viewpoint of dose distribution analysis
Authors:
- Minoru SuzukiMSMinoru Suzuki
- Yoshinori SakuraiYSYoshinori Sakurai
- Shinichiro MasunagaSMShinichiro Masunaga
- Yuko KinashiYKYuko Kinashi
- Kenji NagataKNKenji Nagata
- Akira MaruhashiAMAkira Maruhashi
- Koji OnoKOKoji Ono
- 1 December 2006
- journal article
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 66 (5) , 1584-1589
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Estimation of future mortality from pleural malignant mesothelioma in Japan based on an age‐cohort modelAmerican Journal of Industrial Medicine, 2005
- Long-term Follow-up of Patients with Malignant Pleural Mesothelioma Receiving High-Dose Adenovirus Herpes Simplex Thymidine Kinase/Ganciclovir Suicide Gene TherapyClinical Cancer Research, 2005
- Malignant mesotheliomaThe Lancet, 2005
- Boron Neutron Capture Therapy of Cancer: Current Status and Future ProspectsClinical Cancer Research, 2005
- Effects of boron neutron capture irradiation on the normal lung of ratsApplied Radiation and Isotopes, 2004
- A preliminary comparative study of two treatment planning systems developed for boron neutron capture therapy: MacNCTPlan and SERAMedical Physics, 2002
- Palliative and therapeutic activity of IL-2 immunotherapy in unresectable malignant pleural mesothelioma with pleural effusionLung Cancer, 2001
- Trimodality management of malignant pleural mesotheliomaEuropean Journal of Cardio-Thoracic Surgery, 2001
- The European mesothelioma epidemicBritish Journal of Cancer, 1999
- The Radiation Biology of Boron Neutron Capture TherapyRadiation Research, 1999